Global Coalition for Adaptive Research - Driving Progress for Patients – Faster. Together.

Driving Progress for Patients – Faster. Together.

Meet GCAR
Discover Our Research
Get News + Publications
Make Progress
DONATE

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

⃪ Back to News + Announcements

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

February 25, 2021 | NEJM

Global Coalition for Adaptive Research (GCAR) is a 501(c)(3) non-profit corporation pioneering collaborative, innovative clinical trials to speed the discovery and development of cures.

DRIVING PROGRESS FOR PATIENTS — FASTER. TOGETHER.

FOR PARTICIPATING TRIAL LOCATIONS

GBM AGILE
Resource Portal

QUICK LINKS

Meet GCAR
Discover Our Research
GBM AGILE
DOD M-PACT PTSD
REMAP-CAP / COVID
Get News + Publications
Make Progress
Donate

RECENT POSTS

NEWS + ANNOUNCEMENTS

Knoa Pharma and GCAR Announce First Newly Diagnosed Glioblastoma Patient Randomized in Phase 2/3 GBM AGILE Evaluation of Tinostamustine and First Recurrent Patient Dosed

Colorectal Cancer Alliance and GCAR Announce Collaboration to Advance a Groundbreaking Adaptive Clinical Trial Platform for Colorectal Cancer: KLEOS

GENERAL INQUIRIES

PARTNER INQUIRIES

©2026 GLOBAL COALITION FOR ADAPTIVE RESEARCH. ALL RIGHTS RESERVED. • PRIVACY